Pathophysiology

1. The Two Classical Theories — And Why Both Are Right

For more than a century the pathogenesis of Charcot neuroarthropathy was framed as a contest between two theories advanced in the 1860s–70s:

The modern synthesis — articulated by Jeffcoate, Game, Cavanagh, and others between 2000 and 2015 — recognises that both processes contribute, in series:

1. Autonomic neuropathy dilates foot arterioles → hyperaemia → increased osteoclastic activity.
2. Sensory neuropathy abolishes the protective response to a precipitating injury (sprain, surgery, ulcer).
3. Continued weight-bearing on a now-resorbing bone fragments it.
4. Bone microdamage releases DAMPs and cytokines that propagate further osteoclastic activation via RANK-L.
5. The resulting positive-feedback loop — inflammation → resorption → mechanical failure → more inflammation — is acute Charcot.

In this synthesis the neurovascular theory describes the preconditioning; the neurotrophic theory describes the trigger; and the inflammatory loop is the amplifier. The next sections take each in turn.

2. The Neurotrophic Theory — Loss of Protective Sensation

Sensory and proprioceptive feedback normally protects joints by:

• Triggering pain and reflex unloading after injury.
• Modulating muscle co-contraction to stabilise joints during gait.
• Providing positional awareness that limits extremes of motion.

In a length-dependent diabetic polyneuropathy these are progressively lost distally. By the time CN occurs, virtually all patients have lost 5.07 monofilament sensation (loss of protective sensation, LOPS), 128 Hz vibration sense, and Achilles reflex. Brand (Hansen-disease researcher whose insights translated directly to diabetes; The Insensitive Foot, 1991) coined the principle:“the foot fails when pain fails to protect it.”

The classical demonstration is from Hansen disease: leprosy patients with dense sensory loss in the foot develop CN identical to that of diabetics, even though leprosy bacterial load is concentrated in skin and nerves rather than bone. The arthropathy is therefore not an effect of the underlying disease per se, but of the common downstream sensory deficit.

Mechanically, the loss of protective sensation translates into repeated weight-bearing on an injured foot — the “walking on a fractured foot” phenomenon that produces the dramatic radiographic destruction seen in Part IV. A normal patient with a similar fracture would unload the limb within minutes.

3. The Neurovascular Theory — Hyperaemia and Bone Resorption

Charcot’s original insight — that the joint destruction reflects a direct neural lesion of bone — survives, mechanistically updated, in the modern recognition of autonomic-mediated hyperaemia.

Sympathetic vasoconstrictor fibres normally maintain arteriolar tone in the foot. When they degenerate — as they do early in diabetic neuropathy — vessels lose their vasoconstrictor brake. The result is functional autosympathectomy: the foot receives a sustained, several-fold increase in blood flow. This is the physiological basis of the warm, dry, distended-vein neuropathic foot seen in chronic diabetes.

Doppler and plethysmographic studies (Edmonds et al., Q J Med 1985, Diabetologia 1985) confirmed in early CN feet:

• Foot blood flow ~2–3× normal in active CN.
• Loss of normal nocturnal vasoconstriction.
• Bounding pulses despite small-vessel disease elsewhere.
• Increased venous oxygenation, evidence of true arteriovenous shunting.

Hyperaemia drives bone resorption. Bone is plastic: mechanical and metabolic signals shift the balance of formation and resorption. Increased perfusion brings more osteoclast precursors, more cytokines, and a slightly more acidic, metabolically active milieu — all favourable to osteoclast differentiation and survival. The bone-mineral density of the affected foot drops measurably within weeks of acute CN onset (Petrova et al., Diabet Med 2007).

4. Autonomic Dysregulation — The Common Final Pathway

The autonomic nervous system in the foot is small-fibre. C-fibres (unmyelinated) and small Aδ-fibres (lightly myelinated) carry both nociception and autonomic efferent traffic. In diabetes these are disproportionately damaged — the basis of the so-called small-fibre neuropathy that precedes large-fibre involvement.

• Sudomotor failure — the foot is dry; cracks in the heel are common; sweating absent. The dryness itself predisposes to fissures and ulcers.
• Vasomotor failure — loss of arteriolar tone → hyperaemia (above) → AV shunting (Boulton, Diabetes Care 1985).
• Bone-vascular failure — sympathetic fibres innervate intraosseous vessels and modulate bone perfusion directly. Their loss decouples bone perfusion from systemic regulation.
• Calcitonin-gene-related peptide (CGRP) loss — CGRP-positive C-fibres normally release CGRP into bone, which inhibits osteoclasts via OPG induction. CGRP-fibre loss in CN is one of the molecular “de-brakings” of bone resorption (La Fontaine et al., JFAS 2008).

Quantitative sudomotor axon-reflex testing (QSART) and laser-Doppler flare testing both confirm small-fibre dysfunction in CN even at presentation. The feet of acute CN patients show a striking pattern: dry skin, prominent dorsal veins, and a temperature differential at the bedside that can be measured with a cheap infrared thermometer.

5. RANK / RANK-L / OPG — The Molecular Engine of Osteolysis

The dominant biological insight of the past 20 years has been the identification of the RANK / RANK-Ligand / OPG axis as the molecular engine of CN bone destruction. RANKL was discovered by Lacey, Dougall, and Anderson (Cell 1998); osteoprotegerin by Simonet et al. (Cell 1997). Together they form the rheostat of osteoclast differentiation:

The active equation of bone homeostasis is therefore the local RANKL : OPG ratio:

In acute CN, RANKL is markedly upregulated while OPG is variably altered, and the RANKL:OPG ratio rises. Mabilleau, Petrova, Edmonds and Sabokbar (Diabetologia 2008; Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-κB ligand) demonstrated this in vitro: peripheral-blood monocytes from acute-CN patients cultured in the presence of RANKL produced ~3× more osteoclasts and resorbed ~5× more bone area than control monocytes. The phenotype was intrinsic to the patient’s monocytes — suggesting a systemic priming, not just a local hyperaemia.

Pro-inflammatory cytokines amplify RANKL. TNF-α, IL-1β, and IL-6 upregulate RANKL on stromal cells and synergise with RANK signalling. They are elevated in plasma during acute CN (Petrova et al., Diabetologia 2008). The same cytokines sit at the centre of diabetic chronic low-grade inflammation and obesity-associated insulin resistance — a hint that systemic metabolic disease, not just neuropathy, primes the bone for resorption.

6. The Inflammatory Cascade

Acute CN is, in essence, a localised sterile osteo-articular inflammation. Jeffcoate, Game and Cavanagh (Lancet 2005; Theories concerning the pathogenesis of the acute Charcot foot) made the central argument that the trigger is not a single neural lesion but rather an inappropriate inflammatory amplification of an unrecognised injury.

Their model:

1. Initiating injury — sprain, fall, surgery, or revascularisation.
2. Tissue damage releases DAMPs — HMGB1, S100, ATP, hyaluronic-acid fragments.
3. DAMPs trigger TLR4 / NLRP3 on resident macrophages and infiltrating monocytes.
4. Local secretion of TNF-α, IL-1β, IL-6.
5. Cytokines induce stromal RANKL; OPG variably suppressed.
6. Osteoclast differentiation & activation; bone resorption.
7. Continued weight-bearing (because of LOPS) creates more microdamage — more DAMPs — more cytokines.
8. Self-sustaining loop until cooling occurs by offloading or by exhaustion.

Two features distinguish CN inflammation from a generic post-traumatic response:

• Failure of resolution — the off-switch (resolvins, lipoxins) is impaired in chronic diabetic inflammation; the loop persists where it would normally subside in days.
• No nociceptive feedback — the patient continues to load the joint, supplying fresh microtrauma and DAMPs.

CRP and ESR are typically only modestly elevated in acute CN — useful when high (likely concurrent infection) but unreliable when normal. Local cytokines vastly exceed plasma cytokines.

7. Microtrauma & Mechanical Loading

The load-bearing axis of the foot passes through the medial tarsometatarsal complex — precisely the region most often involved in CN. Several mechanical factors converge:

• Equinus contracture — long-standing diabetes shortens the gastrocnemius–soleus complex (AGE-mediated collagen cross-linking + chronic immobility); this drives forefoot/midfoot pressure during stance.
• Limited joint mobility (LJM, “cheiroarthropathy”) — AGE-stiffened joint capsules restrict subtalar and forefoot motion, transferring load to the midfoot.
• Plantar fat-pad atrophy — thinning and forward migration of the metatarsal fat pad raises peak plantar pressures.
• Intrinsic-muscle wasting — motor neuropathy denervates lumbricals and interossei; toes claw, pulling the metatarsal fat pad distally and exposing the metatarsal heads. The same wasting destabilises the longitudinal arch.
• Repetitive submaximal loading — even normal weight-bearing on a destabilised arch produces cumulative microdamage that an anaesthetic patient does not detect.

Plantar pressure mapping (covered in Part III) demonstrates peak pressures in the diabetic neuropathic midfoot up to ~5× normal — the substrate of midfoot Charcot. The threshold pressure above which ulceration is likely (often quoted ~70 N·cm⁻²) is routinely exceeded in untreated neuropathic feet.

The mechanical model unifies neatly with the inflammatory model: the precipitating insult is a microfracture or capsuloligamentous tear at a site of elevated pressure; absence of pain prevents unloading; weight-bearing mechanically propagates the lesion; biology amplifies it.

8. AGEs & Diabetic Bone

Diabetes is itself a disease of bone — a fact that is older than the recognition of CN but newly relevant. Chronic hyperglycaemia produces non-enzymatic glycation of long-lived proteins: glucose reacts with lysine ε-amines to form Schiff bases → Amadori products → advanced glycation end-products (AGEs): pentosidine, carboxymethyl-lysine, glucosepane.

AGEs accumulate in:

• Bone collagen — cross-linking type-I collagen makes bone biomechanically stiffer but more brittle. Bone-mineral density (BMD) measurements may even be normal or high while material-level toughness is degraded.
• Tendon and ligament collagen — produces the “diabetic stiff hand” (cheiroarthropathy) and equinus contracture in the foot.
• Vascular basement membranes — contributes to microvascular complications.
• Cartilage — AGE-modified cartilage is less compliant, less resilient.

AGEs activate RAGE (receptor for AGEs) on monocytes/macrophages and osteoclast precursors. RAGE signalling upregulates NF-κB, generates ROS, and amplifies pro-inflammatory cytokine production — tying chronic glycaemic exposure directly to the inflammatory cascade of acute CN. Patients with CN have elevated tissue and plasma AGEs and RAGE expression compared with diabetic controls (Witzke et al., Diabetes Care 2011).

9. The Unified Model

Putting it together — the modern, integrated pathogenesis of acute Charcot neuroarthropathy:

1. Substrate. Long-duration diabetes (or other neuropathy) → sensory + motor + autonomic small-fibre loss; AGE-stiffened, brittle bone and ligaments.
2. Preconditioning. Autonomic loss of vasoconstrictor tone → chronic foot hyperaemia → baseline mild osteopenia.
3. Trigger. An often-trivial mechanical event — sprain, fracture, post-op, post-revascularisation.
4. Failure of protective response. Loss of nociception → continued weight-bearing on the injured foot.
5. Inflammatory amplification. Damaged tissue releases DAMPs → TLR4 / NLRP3 → TNF-α, IL-1β, IL-6 → stromal RANKL upregulation.
6. Osteolysis. RANKL:OPG ratio rises, M-CSF abundant; osteoclast differentiation and activation; bone resorption outpaces formation.
7. Mechanical failure. Resorbing bone fractures and dislocates under continued load → characteristic radiographic destruction (Eichenholtz I).
8. Self-sustaining loop. More damage → more DAMPs → more cytokines → more resorption.
9. Resolution. Offloading (TCC) breaks the mechanical input; cytokine drive falls; coalescence (Eichenholtz II) and consolidation (Eichenholtz III) follow over months.

The therapeutic implication is direct — and underwritten by every consensus document since 2011: the single highest-yield intervention is prompt and absolute offloading, by total contact casting if at all possible. Anti-resorptives, anti-inflammatories, and growth factors are biologically appealing but clinically secondary. The mechanical input must be removed for the molecular cascade to abate.

The next part dives into the substrate — the diabetic foot: the Semmes-Weinstein monofilament, peak plantar pressures, the IWGDF risk system, and the integration of CN with the broader diabetic-foot syndrome. Bone-cell biology underlying RANK / RANKL / OPG is treated in more detail in the Cell Physiology course.